Cargando…
iTRAQ-Based Proteomics Screen identifies LIPOCALIN-2 (LCN-2) as a potential biomarker for colonic lateral-spreading tumors
The improvement and implementation of a colonoscopy technique has led to increased detection of laterally spreading tumors (LSTs), which are presumed to constitute an aggressive type of colonic neoplasm. Early diagnosis and treatment of LSTs is clinically challenging. To overcome this problem, we em...
Autores principales: | Wang, Xianfei, Li, Aimin, Guo, Yubin, Wang, Yadong, Zhao, Xinhua, Xiang, Li, Han, Zelong, Li, Yue, Xu, Wen, Zhuang, Kangmin, Yan, Qun, Zhong, Jietao, Xiong, Jing, Liu, Side |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919649/ https://www.ncbi.nlm.nih.gov/pubmed/27339395 http://dx.doi.org/10.1038/srep28600 |
Ejemplares similares
-
Clinicopathological Characteristics of Laterally Spreading Colorectal Tumor
por: Zhao, Xinhua, et al.
Publicado: (2014) -
The effect of lipocalin-2 (LCN2) on apoptosis: a proteomics analysis study in an LCN2 deficient mouse model
por: Wu, Dongming, et al.
Publicado: (2021) -
Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and Therapy
por: Asimakopoulou, Anastasia, et al.
Publicado: (2016) -
Lipocalin 2 (LCN2) is a promising target for cholangiocarcinoma treatment and bile LCN2 level is a potential cholangiocarcinoma diagnostic marker
por: Chiang, Kun-Chun, et al.
Publicado: (2016) -
LCN6, a novel human epididymal lipocalin
por: Hamil, Katherine G, et al.
Publicado: (2003)